LIU Qing-ping, LI Nan, SUN Jun-wei, et al. Effect of Duanteng Yimu Decoction on Bone Destruction in Rats with Adjuvant Arthritis[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(10): 146-149.
LIU Qing-ping, LI Nan, SUN Jun-wei, et al. Effect of Duanteng Yimu Decoction on Bone Destruction in Rats with Adjuvant Arthritis[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(10): 146-149. DOI: 10.13422/j.cnki.syfjx.2015100146.
Objective: To explore the effect of duanteng Yimu decoction (DTYM) on anti-inflammation and counteracting bone destruction
and to investigate its mechanism of counteracting bone destruction of adjuvant arthritis in rats. Method: Seventy-two SD rats were divided into nine groups;the normal group
the model group
the methotrexate group (MTX
1.06 mg · kg-1)
the high-
medium-
low-dose celastrus orbiculatus groups (47
23.5
4.7 g · kg-1) and the high-
medium-
low-dose DTYM groups (94
47
9.4 g · kg-1). The rats except the normal group were induced by injecting complete Freund's adjuvant to establish adjuvant arthritis rat model. After intragastrical administration of the corresponding medicines once daily for 36 days
the feet swelling degrees
ankle X-ray
C-terminal telopeptide of type I collagen (CTX-I) and N-terminal propeptide of type I collagen (PINP) serum concentration
and ankle pathological were observed. Result: Compared with the normal group
the feet swelling degrees
CTX-I and ankle X-ray score increased significantly in the model group (P<0.01). Compared with the model group
the feet swelling degrees
CTX-I and ankle X-ray score decreased significantly in all treatment groups (P<0.01). No statistically significant differences in PINP were found between any two groups. Pathological study showed that there were less synovial cell hyperplasia
inflammatory cell infiltrations
pannus formation and cartilage destruction in all treatment groups. Moreover
the above results were better in the DTYM groups. Conclusion: The mechanism of DTYM decoction in improving arthritis and bone destruction may be related to inhibiting the level of CTX-I.